Lynx1 Capital Management LP - Insider Non-Derivative Transactions at Cullinan Oncology, Inc. (CGEM) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Oct 17, 2025, Lynx1 Capital Management LP's relationship to Cullinan Oncology, Inc. (CGEM) is TenPercentOwner, and currently has 8,564,116 shares of Common stock, $0.0001 par value per share ("Common Stock"), and 8,797,833 shares of Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CGEM insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of CGEM Common stock, $0.0001 par value per share ("Common Stock")

Lynx1 Capital Management LP - Insider Non-Derivative Transactions of CGEM Common Stock

Lynx1 Capital Management LP - Insider Non-Derivative Transactions at CGEM

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 18, 2025	P -- (Common Stock)	32217	7.84	8797833
Oct 17, 2025	P -- (Common Stock)	150000	8.86	8765616
Oct 16, 2025	P -- (Common Stock)	51500	7.94	8615616
Oct 15, 2025	P -- (Common stock, $0.0001 par value per share ("Common Stock"))	15032	7.59	8564116
Oct 11, 2025	P -- (Common Stock)	277298	7.36	8549084
Oct 10, 2025	P -- (Common Stock)	626043	6.7	8271786
Oct 9, 2025	P -- (Common stock, $0.0001 par value per share ("Common Stock"))	556300	6.46	7645743